Let's dig deeper into why analysts think BHP Group Ltd (ASX: BHP) and these ASX shares could be in the buy zone right ...

ASX healthcare shares surged 21% over the past month. Can CSL, ResMed, and Cochlear keep climbing into the future?

Shares of medical device company ResMed (NYSE:RMD) jumped 3.7% in the afternoon session after it was added to Goldman Sachs' ...

Air Voel continues to strengthen its commitment to improving sleep health for Canadians by providing dependable ResMed BiPAP ...

Shares of ResMed (RMD) have gained 6.6% over the past four weeks to close the last trading session at $194.88, but there ...

Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2026 on Thursday, August 6, 2026, after the New York Stock ...

Investors in ResMed Inc. RMD need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $200.00 Call had some of the highest implied ...

TheFly reported on June 22 that KeyBanc adjusted its price target for RMD to $266 from $290 while maintaining an Overweight ...

If you know anyone sleeping more soundly thanks to a CPAP machine, thank Peter Farrell, SM ’67. He founded Resmed, the ...

The rocket company was priced at US$135 per share on June 11, giving it a value of roughly US$1.75 trillion. By the close of ...

Onera hPSG®, an end-to-end home polysomnography solution from Onera Health, is now integrated into Somnoware, enabling their shared customers to conduct Polysomnography tests (PSGs) in the patient's ...

ResMed’s $340 million acquisition of Noctrix Health adds a wearable neuromodulation device for restless legs syndrome to its sleep portfolio. (iStock/Getty Images Plus) ResMed has closed its $340 ...